Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay
Newest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment ANN...
Pregnancy
10 Ways to Geek Out on FSA-eligible High-tech Health from FSA Store® and Spend Tax-free Funds Before the December 31 Flexible Spending Account (FSA) Deadline
From trending products like light therapy devices, baby health monitors, and wearable diagnostic trackers, use FSA funds to gift health...
What is a “Mommy Makeover” and Who is It For? Dr. Ember Ewings Shares Her Perspective
Dr. Ember Ewings provides insight into modern mommy makeover planning, emphasizing personalized treatment, realistic expectations, and long-term results for patients...
Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization
SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused...
GE HealthCare builds on a century of innovation to shape the future of radiology at RSNA 2025
The company will showcase a wave of transformative innovations designed to address the most pressing challenges in healthcare, spanning the...
KOMZIFTI™ (ziftomenib) Added to National Comprehensive Cancer Network® (NCCN) Guidelines for Acute Myeloid Leukemia (AML)
KOMZIFTI, the first and only once-daily FDA-approved menin inhibitor for R/R NPM1-mutated AML, is now commercially available in the United...
Sera Announces Publication Acceptance for PRIME Study
The PRIME study, one of the largest studies on preterm birth, has been accepted for publication by a medical journal...
Daré Bioscience Receives $3.6 Million in Additional Grant Funding
Grant funding will support continued progress on a preclinical research program to identify and develop a non-hormonal intravaginal contraceptive innovation...
Dionysus Health Appoints Digital Health Leader Rashmi Raghavendra as Chief Executive Officer
New CEO to Lead Company from Groundbreaking Science to Commercial Launch in Maternal Mental Health DiagnosticsSEATTLE, Nov. 22, 2025 /PRNewswire/...
Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration
Leading edge artificial intelligence and machine learning platform supports enhanced salesforce targeting and engagement for cutaneous T-cell lymphoma immunotherapy launchCRANFORD,...
The Rise of Advanced Maternal Age IVF: BaseCare Medical’-B(2170.HK) AI “Undisturbed Culture” Empowers Intelligent Assisted Reproduction
SUZHOU, China, Nov. 19, 2025 /PRNewswire/ -- Data from the keynote report at the 18th Annual Conference of the Chinese...
TG Therapeutics Makes 2025 Deloitte Technology Fast 500™ List of America’s Fastest-Growing Companies
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number 27 on the...
Libtayo® (cemiplimab) Approved in the European Union as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with High Risk of Recurrence after Surgery and Radiation
Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free...
FamilyWell Health Announces $8M Series A Funding to Accelerate Nationwide Expansion of Integrated Women’s Mental Health Care
Building on its success in maternal mental health, funding will accelerate FamilyWell’s growth into menopause care, advance its AI-enabled digital...
Biosensors Market Dominated by Electrochemical Sensors with 72% Revenue Share, as Global Biosensors Market Size is set to Surpass USD 42B by 2030, Says Mordor Intelligence
HYDERABAD, India, Nov. 18, 2025 /PRNewswire/ -- According to Mordor Intelligence, the global biosensors market is valued at USD 28.50 billion in 2025...
Kingsway Pharmaceuticals Acquires Strategic Equity Stake in CIGA Healthcare to Expand Access to At-Home and Retail Diagnostic Testing
BRISTOL, Tenn., Nov. 17, 2025 /PRNewswire/ -- Kingsway Pharmaceuticals, a U.S.-based consumer healthcare company specializing in nationally distributed OTC brands...
GE HealthCare announces Flyrcado milestone: Strong pilot results drive broader rollout at CVAUSA
CVAUSA, the largest network of private cardiology groups in the U.S., plans to broadly adopt Flyrcado in line with its...
Pinnacle Fertility Expands National Network with the Addition of Tulsa Fertility Center
SCOTTSDALE, Ariz., Nov. 14, 2025 /PRNewswire/ -- Tulsa Fertility Center, a leading provider of reproductive medicine and one of Oklahoma's...
SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
SALT LAKE CITY, Nov. 13, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and...
Welldoc Cements AI Leadership with Dedicated AI Lab and 100+ Clinical Publications
Welldoc's Strategic Investment Accelerates Research and Development of Novel AI-Powered Hyper-personalization Capabilities at ScaleCOLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered...